Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine for Sleep in Children With Autism
NCT05501678Phase 2Recruiting
- Sponsor
- Stanford University
- Start
- Aug 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diphenhydramine in sleep disorder, sponsored by Stanford University. Started Aug 2023; status: recruiting.
02
Drugs
diphenhydramine
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT05501678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05501678.